Literature DB >> 29243007

Comparison of Telephone and Televideo Modes for Delivery of Genetic Counseling: a Randomized Trial.

Corrine I Voils1,2, Vickie L Venne3, Hollis Weidenbacher4, Nina Sperber4,5, Santanu Datta5.   

Abstract

Telephone and televideo have yielded equivalent patient satisfaction and psychosocial outcomes when compared to in-person genetic counseling, yet little is known about how they compare to one another. In this randomized controlled trial, veterans received genetic counseling via telephone or traveled to a clinic to participate via encrypted televideo. Knowledge and visit satisfaction were assessed 2 weeks later. Travel time, mileage, and out-of-pocket costs were calculated for videoconferencing. Qualitative interviews were conducted with patients and counselors to assess acceptability. Of the 20 male patients randomized to telephone, 90% received counseling and provided outcomes; of the 18 randomized to televideo, 67% received counseling and 50% provided outcomes. Telephone patients answered a mean of 4.4 of eight questions correctly at baseline and 4.7 at follow-up; televideo means were 5.6 and 6.5, respectively. Satisfaction was 25.2 out of 30 for telephone and 26.9 for televideo. Televideo patients incurred a median of 2.8 h of travel time, 40 roundtrip miles, and $67.29 in costs. Patients and counselors found both modes acceptable for providing education and answering questions. Although patients liked the flexibility of telephone, counselors felt patients missed more appointments and were distracted when using telephone. A noted advantage of videoconferencing was reading body language. Further evaluation of alternative delivery modes is needed.

Entities:  

Keywords:  Genetic counseling; Knowledge; Patient satisfaction; Telemedicine; Telephone; Televideo

Mesh:

Year:  2017        PMID: 29243007     DOI: 10.1007/s10897-017-0189-1

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  12 in total

Review 1.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

2.  Introduction to the "Technology in Practice" Special Issue.

Authors:  Vickie Venne; Megan Doerr
Journal:  J Genet Couns       Date:  2018-03-01       Impact factor: 2.537

3.  The potential impact of allied health professional telehealth consultations on health inequities and the burden of treatment.

Authors:  Nicola Eddison; Enza Leone; Aoife Healy; Carolyn Royse; Nachiappan Chockalingam
Journal:  Int J Equity Health       Date:  2022-06-30

4.  Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network.

Authors:  Georgia L Wiesner; Alanna Kulchak Rahm; Paul Appelbaum; Sharon Aufox; Sarah T Bland; Carrie L Blout; Kurt D Christensen; Wendy K Chung; Ellen Wright Clayton; Robert C Green; Margaret H Harr; Nora Henrikson; Christin Hoell; Ingrid A Holm; Gail P Jarvik; Iftikhar J Kullo; Philip E Lammers; Eric B Larson; Noralane M Lindor; Maddalena Marasa; Melanie F Myers; Josh F Peterson; Cynthia A Prows; James D Ralston; Hila Milo Rasouly; Richard R Sharp; Maureen E Smith; Sara L Van Driest; Janet L Williams; Marc S Williams; Julia Wynn; Kathleen A Leppig
Journal:  J Pers Med       Date:  2020-04-27

Review 5.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

6.  Experiences and Beliefs of Low-Income Patients With Hypertension in Louisiana and Mississippi During the COVID-19 Pandemic.

Authors:  Katherine T Mills; Erin Peacock; Jing Chen; Amanda Zimmerman; Hua He; Alecia Cyprian; Gerrelda Davis; Sonja R Fuqua; Darie S Gilliam; Angelique Greer; Lea Gray-Winfrey; Shondra Williams; Gary M Wiltz; Keith L Winfrey; Paul K Whelton; Marie Krousel-Wood; Jiang He
Journal:  J Am Heart Assoc       Date:  2020-12-03       Impact factor: 5.501

7.  Videoconferencing to deliver genetics services: a systematic review of telegenetics in light of the COVID-19 pandemic.

Authors:  Elizabeth G Brown; Isabella Watts; Emily R Beales; Ashwini Maudhoo; Judith Hayward; Eamonn Sheridan; Imran Rafi
Journal:  Genet Med       Date:  2021-04-06       Impact factor: 8.822

8.  Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial.

Authors:  Kimberly A Kaphingst; Wendy Kohlmann; Rachelle Lorenz Chambers; Melody S Goodman; Richard Bradshaw; Priscilla A Chan; Daniel Chavez-Yenter; Sarah V Colonna; Whitney F Espinel; Jessica N Everett; Amanda Gammon; Eric R Goldberg; Javier Gonzalez; Kelsi J Hagerty; Rachel Hess; Kelsey Kehoe; Cecilia Kessler; Kadyn E Kimball; Shane Loomis; Tiffany R Martinez; Rachel Monahan; Joshua D Schiffman; Dani Temares; Katie Tobik; David W Wetter; Devin M Mann; Kensaku Kawamoto; Guilherme Del Fiol; Saundra S Buys; Ophira Ginsburg
Journal:  BMC Health Serv Res       Date:  2021-06-02       Impact factor: 2.655

9.  Early Outcome Data Assessing Utility of a Post-Test Genomic Counseling Framework for the Scalable Delivery of Precision Health.

Authors:  Amy C Sturm; Tara Schmidlen; Laura Scheinfeldt; Shelly Hovick; Joseph P McElroy; Amanda E Toland; J Scott Roberts; Kevin Sweet
Journal:  J Pers Med       Date:  2018-07-25

10.  Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors.

Authors:  Cara N Cacioppo; Brian L Egleston; Dominique Fetzer; Colleen Burke Sands; Syeda A Raza; Neeraja Reddy Malleda; Elisabeth McCarty Wood; India Rittenburg; Julianne Childs; David Cho; Martha Hosford; Tina Khair; Jamil Khatri; Lydia Komarnicky; Trina Poretta; Fahd Rahman; Satish Shah; Linda J Patrick-Miller; Susan M Domchek; Angela R Bradbury
Journal:  Cancer Med       Date:  2021-06-08       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.